This study investigates whether KMUP-1 protects soluble guanylate cyclase (sGC) and inhibits vascular endothelial growth factor (VEGF) expression in lung epithelial cells in hypoxia, therapeutically targeting epithelial proinflammation. H441 cells were used as a representative epithelial cell line to examine the role of sGC and VEGF in hypoxia and the anti-proinflammatory activity of KMUP-1 in normoxia. Human H441 cells were grown in hypoxia for 24–72 h. KMUP-1 (1,10,100 μM) arrested cells at the G0/G1 phase of the cell cycle, reduced cell survival and migration, increased p21/p27, restored eNOS, increased soluble guanylate cyclase (sGC) and PKG and inhibited Rho kinase II (ROCK-II). KMUP-1 (0.001−0.1 μM) concentration dependently increased eNOS in normoxia and did not inhibit phosphodiesterase-5A (PDE-5A) in hypoxic cells. Hypoxia-induced factor-1α (HIF-1α) and VEGF were suppressed by KMUP-1 but not by L-NAME (100 μM). The PKG inhibitor Rp-8-CPT-cGMPS (10 μM) blunted the inhibition of ROCK-II by KMUP-1. KMUP-1 inhibited thromboxane A2-mimetic agonist U46619-induced PDE-5A, TNF-α (100 ng/ml)-induced iNOS, and ROCK-II and associated phospho-p38 MAPK, suggesting multiple anti-proinflammatory activities. In addition, increased p21/p27 by KMUP-1 at higher concentrations might contribute to an increased Bax/Bcl-2 and active caspase-3/procaspase-3 ratio, concomitantly causing apoptosis. KMUP-1 inhibited ROCK-II/VEGF in hypoxia, indicating its anti-neoplastic and anti-inflammatory properties. KMUP-1 inhibited TNF-α-induced iNOS and U46619-induced PDE-5A and phospho-p38 MAPK in normoxia, confirming its anti-proinflammatory action. KMUP-1 could be used as an anti-proinflammatory agent to reduce epithelial inflammation.
JainMSznajderJI. Effects of hypoxia on the alveolar epithelium. Proc Am Thorac Soc2005; 2: 202–5.
2.
KirschMKemp-HarperBWeissmannNGrimmingerFSchmidtHH. Sildenafil in hypoxic pulmonary hypertension potentiates a compensatory up-regulation of NO-cGMP signaling. FASEB J2008; 22:30–40.
3.
TakahashiHShibuyaM. The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions. Clin Sci (Lond)2005; 109:227–41.
4.
ChungHHDaiZKWuBNYehJLChaiCYChuKSLiuCPChenIJ. The xanthine derivative KMUP-1 inhibits models of pulmonary artery hypertension via increased NO and cGMP-dependent inhibition of RhoA/Rho kinase. Br J Pharmacol2010; 160:971–86.
5.
ChungHHDaiZKWuBNYehJLChaiCYChuKSLiuCPChenIJ. KMUP-1 inhibits pulmonary artery proliferation by targeting serotonin receptors/transporter and NO synthase, inactivating RhoA and suppressing AKT/ERK phosphorylation. Vascul Pharmacol2010; 53:239–49.
6.
DaiZKChengYJChungHHWuJRChenIJWuBN. KMUP-1 ameliorates monocrotaline-induced pulmonary arterial hypertension through the modulation of Ca2+ sensitization and K+-channel. Life Sci2010; 86:747–55.
7.
WuBNLinRJLinCYShenKPChiangLCChenIJ. A xanthine-based KMUP-1 with cyclic GMP enhancing and K+ channels opening activities in rat aortic smooth muscle. Br J Pharmacol2001; 134: 265–74.
8.
LinRJWuBNLoYCShenKPLinYTHuangCHChenIJ. KMUP-1 relaxes rabbit corpus cavernosum smooth muscle in vitro and in vivo: Involvement of cyclic GMP and K+ channels. Br J Pharmacol2002; 135:1159–66.
9.
WuBNLinRJLoYCShenKPWangCCLinYTChenIJ. KMUP-1, a xanthine derivative, induces relaxation of guinea-pig isolated trachea: The role of the epithelium, cyclic nucleotides and K+ channels. Br J Pharmacol2004; 142:1105–14.
10.
WuBNTuHFWelshDGChenIJ. KMUP-1 activates BKCa channels in basilar artery myocytes via cyclic nucleotide-dependent protein kinases. Br J Pharmacol2005; 146:862–71.
11.
WuBNChenCWLiouSFYehJLChungHHChenIJ. Inhibition of proinflammatory tumor necrosis factor-{alpha}-induced inducible nitric-oxide synthase by xanthine-based 7-[2-[4-(2-chlor obenzene)piperazinyl]ethyl]-1,3-dimethylxanthine (KMUP-1) and 7-[2-[4-(4-nitrobenzene)piperaz inyl]ethyl]-l, 3-dimethylxanthine (KMUP-3) in rat trachea: The involvement of soluble guanylate cyclase and protein kinase G. Mol Pharmacol2006; 70:977–85.
12.
KhooNKFreemanBA. Electrophilic nitro-fatty acids: Anti-inflammatory mediators in the vascular compartment. Curr Opin Pharmacol2010; 10:179–84.
13.
RicePLPetersSLBeardKSAhnenDJ. Sulindac independently modulates extracellular signal-regulated kinase 1/2 and cyclic GMP-dependent protein kinase signaling pathways. Mol Cancer Ther2006; 5:746–54.
14.
ZhuBVemavarapuLThompsonWJStradaSJ. Suppression of cyclic GMP-specific phosphodiesterase 5 promotes apoptosis and inhibits growth in HT29 cells. J Cell Biochem2005; 94:336–50.
15.
WhartonJStrangeJWMollerGMGrowcottEJRenXFranklynAPPhillipsSCWilkinsMR. Antiproliferative effects of phosphodiesterase type 5 inhibition in human pulmonary artery cells. Am J Resp Crit Care Med2005; 172:105–13.
16.
WangSWPanSLGuhJHChenHLHuangDMChangYLKuoSCLeeFYTengCM. YC-1 [3-(5′-Hydroxymethyl-2′-furyl)-1-benzyl Indazole] exhibits a novel antiproliferative effect and arrests the cell cycle in G0-G1 in human hepatocellular carcinoma cells. J Pharmacol Exp Ther2005; 312: 917–25.
17.
PanSLGuhJHPengCY. YC-1 [3-(5′-hydroxymethyl-2′-furyl)-1-benzyl indazole] inhibits endothelial cell functions induced by angiogenic factors in vitro and angiogenesis in vivo models. J Pharmacol Exp Ther2005; 314:35–42.
18.
HuangYTPanSLGuhJHChangYLLeeFYKuoSCTengCM. YC-1 suppresses constitutive nuclear factor-kappaB activation and induces apoptosis in human prostate cancer cells. Mol Cancer Ther2005; 4:1628–35.
19.
ChangMSLeeWSChenBCSheuJRLinCH. YC-1-induced cyclooxygenase-2 expression is mediated by cGMP-dependent activations of Ras, phosphoinositide-3-OH-kinase, Akt, and nuclear factor-kappaB in human pulmonary epithelial cells. Mol Pharmacol2004; 66:561–71.
20.
DingJLiQYWangXSunCHLuCZXiaoBG. Fasudil protects hippocampal neurons against hypoxia-reoxygenation injury by suppressing microglial inflammatory responses in mice. J Neurochem2010; 114:1619–29.
21.
LiuCMLoYCWuBNWuWJChouYHHuangCHAnLMChenIJ. cGMP-enhancing- and alphalA/alpha1 D-adrenoceptor blockade-derived inhibition of Rho-kinase by KMUP-1 provides optimal prostate relaxation and epithelial cell anti-proliferation efficacy. Prostate2007; 67:1397–410.
22.
GhisoNRohanRMAmanoSGarlandRAdamisAP. Suppression of hypoxia-associated vascular endothelial growth factor gene expression by nitric oxide via cGMP. Invest Ophthalmol Vis Sci1999; 40:1033–9.
23.
MizukamiYFujikiKDuerrEMGalaMJoWSZhangXChungDC. Hypoxic regulation of vascular endothelial growth factor through the induction of phosphatidylinositol 3-kinase/Rho/ROCK and c-Myc. J Biol Chem2006; 281:13957–63.
24.
ChunYSYeoEJChoiETengCMBaeJMKimMSParkJW. Inhibitory effect of YC-1 on the hypoxic induction of erythropoietin and vascular endothelial growth factor in Hep3B cells. Biochem Pharmacol2001; 61:947–54.
25.
HsuHKJuanSHHoPYLiangYCLinCHTengCMLeeWS. YC-1 inhibits proliferation of human vascular endothelial cells through a cyclic GMP-independent pathway. Biochem Pharmacol2003; 66: 263–71.
26.
YeoEJChunYSChoYSKimJLeeJCKimMSParkJW. YC-1: A potential anticancer drug targeting hypoxia-inducible factor 1. J Natl Cancer Inst2003; 95:516–25.
27.
SatoJNairKHiddingaJEberhardtNLFitzpatrickLAKatusicZSO'BrienT. eNOS gene transfer to vascular smooth muscle cells inhibits cell proliferation via upregulation of p27 and p21 and not apoptosis. Cardiovasc Res2000; 47:697–706.
NathPLeungSYWilliamsA. Importance of p38 mitogen-activated protein kinase pathway in allergic airway remodelling and bronchial hyperresponsiveness. Eur J Pharmacol2006; 544: 160–7.
DeguchiAThompsonWJWeinsteinIB. Activation of protein kinase G is sufficient to induce apoptosis and inhibit cell migration in colon cancer cells. Cancer Res2004; 64:3966–73.
33.
KamarajuAKRobertsAB. Role of Rho/ROCK and p38 MAP Kinase Pathways in transforming growth factor-β-mediated Smad-dependent Growth Inhibition of human breast carcinoma cells in vivo. J Biol Chem2005; 280:1024–36.
34.
MatobaKKawanamiDIshizawaSKanazawaYYokotaTUtsunomiyaK. Rho-kinase mediates TNF-α-induced MCP-1 expression via p38 MAPK signaling pathway in mesangial cells. Biochem Biophys Res Commun2010; 402:725–30.
